PRAX

Praxis Precision Medicines, Inc.

47.50 USD
-1.34 (-2.74%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Praxis Precision Medicines, Inc. stock is up 20.8% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 February’s closed higher than January. In the last 4 Unusual Options Trades, there were 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
04 Jan 17:51 19 Jan, 2024 30.00 CALL 178 32
10 Jan 17:04 15 Mar, 2024 40.00 CALL 65 0
17 Jan 20:15 15 Mar, 2024 40.00 CALL 42 75
24 Jan 20:09 15 Mar, 2024 40.00 CALL 50 175

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression.